Precision Biologics is a biotechnology company dedicated to improving the lives of cancer patients through its innovative therapeutic and diagnostic products.
Our monoclonal antibodies have several mechanisms of action to counteract the tumor growth and two of them (NEO-102 and NEO-201) are in clinical trial for the treatment of several solid tumors.